CompaniesEsperance Pharmaceuticals

Esperance Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

87

By Phase

PHASE2: 1PHASE1: 1

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2008

2009

2010

2011

2012

2013

2014

2015

Today

Hover over trial bars to see details

Recent Trials

NCT01485848Lead Sponsor

EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer

PHASE2Completed

49 participants

Started: Feb 29, 2012 · Completed: May 31, 2014

NCT00949559Lead Sponsor

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

PHASE1Completed

38 participants

Started: Jul 31, 2009 · Completed: Mar 31, 2012

Funding History (4)

D

Jul 12, 2019

D

Jun 9, 2011

D/A

May 3, 2010

D/A

May 3, 2010